Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00349973
Show Display Options
Rank Status Study
1 Completed Clinical Trial of Dipyridamole in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Drug: Dipyridamole;   Other: Olanzapine

Indicates status has not been verified in more than two years